PMV Pharmaceuticals
PMVP
PMVP
55 hedge funds and large institutions have $40.7M invested in PMV Pharmaceuticals in 2025 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 9 increasing their positions, 32 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
72% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 32
85% less call options, than puts
Call options by funds: $2K | Put options by funds: $13K
94% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 16
Holders
55
Holding in Top 10
2
Calls
$2K
Puts
$13K
Top Buyers
| 1 | +$1.33M | |
| 2 | +$306K | |
| 3 | +$178K | |
| 4 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$103K |
| 5 |
PLC
Peapod Lane Capital
Bedford Hills,
New York
|
+$47.6K |
Top Sellers
| 1 | -$604K | |
| 2 | -$540K | |
| 3 | -$486K | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$447K |
| 5 |
SC
Shay Capital
New York
|
-$236K |
